vs
Cooper Companies (The)（COO）与罗布乐思（RBLX）财务数据对比。点击上方公司名可切换其他公司
罗布乐思的季度营收约是Cooper Companies (The)的1.3倍（$1.4B vs $1.1B），Cooper Companies (The)净利率更高（7.9% vs -22.3%，领先30.3%），罗布乐思同比增速更快（43.2% vs 4.6%），罗布乐思自由现金流更多（$308.6M vs $149.9M），过去两年罗布乐思的营收复合增速更高（32.9% vs 6.9%）
CooperCompanies是总部位于美国加利福尼亚州圣拉蒙的全球医疗设备企业，旗下设有两大业务单元：主营隐形眼镜生产的库博光学，以及面向女性健康市场提供医疗设备、生育及基因组相关产品的库博外科。
罗布乐思（Roblox Corporation）是总部位于美国加利福尼亚州圣马特奥的游戏企业，由大卫·巴斯祖奇与埃里克·卡塞尔于2004年共同创立。公司核心产品为同名线上游戏创作平台Roblox，于2006年正式上线，截至2024年12月底全球员工规模已超2400人。
COO vs RBLX — 直观对比
营收规模更大
RBLX
是对方的1.3倍
$1.1B
营收增速更快
RBLX
高出38.6%
4.6%
净利率更高
COO
高出30.3%
-22.3%
自由现金流更多
RBLX
多$158.7M
$149.9M
两年增速更快
RBLX
近两年复合增速
6.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.1B | $1.4B |
| 净利润 | $84.6M | $-316.0M |
| 毛利率 | 61.1% | 77.7% |
| 营业利润率 | 13.2% | -25.3% |
| 净利率 | 7.9% | -22.3% |
| 营收同比 | 4.6% | 43.2% |
| 净利润同比 | -28.0% | -43.9% |
| 每股收益（稀释后） | $0.42 | $-0.44 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收COORBLX
| Q4 25 | $1.1B | $1.4B | ||
| Q3 25 | $1.1B | $1.4B | ||
| Q2 25 | $1.0B | $1.1B | ||
| Q1 25 | $964.7M | $1.0B | ||
| Q4 24 | $1.0B | $988.2M | ||
| Q3 24 | $1.0B | $919.0M | ||
| Q2 24 | $942.6M | $893.5M | ||
| Q1 24 | $931.6M | $801.3M |
净利润COORBLX
| Q4 25 | $84.6M | $-316.0M | ||
| Q3 25 | $98.3M | $-255.6M | ||
| Q2 25 | $87.7M | $-278.4M | ||
| Q1 25 | $104.3M | $-215.1M | ||
| Q4 24 | $117.5M | $-219.6M | ||
| Q3 24 | $104.7M | $-239.3M | ||
| Q2 24 | $88.9M | $-205.9M | ||
| Q1 24 | $81.2M | $-270.6M |
毛利率COORBLX
| Q4 25 | 61.1% | 77.7% | ||
| Q3 25 | 65.3% | 78.2% | ||
| Q2 25 | 67.8% | 78.2% | ||
| Q1 25 | 68.4% | 78.3% | ||
| Q4 24 | 66.5% | 77.9% | ||
| Q3 24 | 66.1% | 77.7% | ||
| Q2 24 | 67.0% | 77.8% | ||
| Q1 24 | 67.0% | 77.7% |
营业利润率COORBLX
| Q4 25 | 13.2% | -25.3% | ||
| Q3 25 | 16.6% | -21.8% | ||
| Q2 25 | 18.4% | -29.8% | ||
| Q1 25 | 18.9% | -24.6% | ||
| Q4 24 | 19.5% | -24.7% | ||
| Q3 24 | 19.2% | -30.4% | ||
| Q2 24 | 17.2% | -26.6% | ||
| Q1 24 | 16.4% | -37.7% |
净利率COORBLX
| Q4 25 | 7.9% | -22.3% | ||
| Q3 25 | 9.3% | -18.8% | ||
| Q2 25 | 8.7% | -25.8% | ||
| Q1 25 | 10.8% | -20.8% | ||
| Q4 24 | 11.5% | -22.2% | ||
| Q3 24 | 10.4% | -26.0% | ||
| Q2 24 | 9.4% | -23.0% | ||
| Q1 24 | 8.7% | -33.8% |
每股收益（稀释后）COORBLX
| Q4 25 | $0.42 | $-0.44 | ||
| Q3 25 | $0.49 | $-0.37 | ||
| Q2 25 | $0.44 | $-0.41 | ||
| Q1 25 | $0.52 | $-0.32 | ||
| Q4 24 | $0.59 | $-0.32 | ||
| Q3 24 | $0.52 | $-0.37 | ||
| Q2 24 | $0.44 | $-0.32 | ||
| Q1 24 | $0.41 | $-0.43 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $110.6M | $3.1B |
| 总债务越低越好 | $2.5B | $1.2B |
| 股东权益账面价值 | $8.2B | $394.5M |
| 总资产 | $12.4B | $9.6B |
| 负债/权益比越低杠杆越低 | 0.30× | 2.98× |
8季度趋势，按日历期对齐
现金及短期投资COORBLX
| Q4 25 | $110.6M | $3.1B | ||
| Q3 25 | $124.9M | $2.9B | ||
| Q2 25 | $116.2M | $2.6B | ||
| Q1 25 | $100.9M | $2.7B | ||
| Q4 24 | $107.6M | $2.4B | ||
| Q3 24 | $109.7M | $2.3B | ||
| Q2 24 | $112.4M | $2.4B | ||
| Q1 24 | $135.2M | $2.4B |
总债务COORBLX
| Q4 25 | $2.5B | $1.2B | ||
| Q3 25 | $2.4B | — | ||
| Q2 25 | $2.5B | — | ||
| Q1 25 | $2.5B | — | ||
| Q4 24 | $2.6B | $1.2B | ||
| Q3 24 | $2.6B | — | ||
| Q2 24 | $2.7B | — | ||
| Q1 24 | $2.7B | — |
股东权益COORBLX
| Q4 25 | $8.2B | $394.5M | ||
| Q3 25 | $8.4B | $407.6M | ||
| Q2 25 | $8.3B | $353.2M | ||
| Q1 25 | $8.1B | $310.7M | ||
| Q4 24 | $8.1B | $221.4M | ||
| Q3 24 | $7.9B | $189.9M | ||
| Q2 24 | $7.8B | $121.5M | ||
| Q1 24 | $7.7B | $71.6M |
总资产COORBLX
| Q4 25 | $12.4B | $9.6B | ||
| Q3 25 | $12.4B | $8.6B | ||
| Q2 25 | $12.4B | $7.8B | ||
| Q1 25 | $12.2B | $7.5B | ||
| Q4 24 | $12.3B | $7.2B | ||
| Q3 24 | $12.1B | $6.7B | ||
| Q2 24 | $12.0B | $6.5B | ||
| Q1 24 | $12.0B | $6.3B |
负债/权益比COORBLX
| Q4 25 | 0.30× | 2.98× | ||
| Q3 25 | 0.29× | — | ||
| Q2 25 | 0.30× | — | ||
| Q1 25 | 0.31× | — | ||
| Q4 24 | 0.32× | 5.48× | ||
| Q3 24 | 0.33× | — | ||
| Q2 24 | 0.34× | — | ||
| Q1 24 | 0.35× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $247.9M | $607.0M |
| 自由现金流经营现金流 - 资本支出 | $149.9M | $308.6M |
| 自由现金流率自由现金流/营收 | 14.1% | 21.8% |
| 资本支出强度资本支出/营收 | 9.2% | 21.1% |
| 现金转化率经营现金流/净利润 | 2.93× | — |
| 过去12个月自由现金流最近4个季度 | $433.7M | $1.4B |
8季度趋势，按日历期对齐
经营现金流COORBLX
| Q4 25 | $247.9M | $607.0M | ||
| Q3 25 | $261.4M | $546.2M | ||
| Q2 25 | $96.2M | $199.3M | ||
| Q1 25 | $190.6M | $443.9M | ||
| Q4 24 | $268.1M | $184.5M | ||
| Q3 24 | $207.5M | $247.4M | ||
| Q2 24 | $111.0M | $151.4M | ||
| Q1 24 | $122.7M | $238.9M |
自由现金流COORBLX
| Q4 25 | $149.9M | $308.6M | ||
| Q3 25 | $164.5M | $443.6M | ||
| Q2 25 | $18.1M | $176.7M | ||
| Q1 25 | $101.2M | $426.5M | ||
| Q4 24 | $128.1M | $120.6M | ||
| Q3 24 | $118.5M | $218.0M | ||
| Q2 24 | $36.9M | $111.7M | ||
| Q1 24 | $4.6M | $192.3M |
自由现金流率COORBLX
| Q4 25 | 14.1% | 21.8% | ||
| Q3 25 | 15.5% | 32.6% | ||
| Q2 25 | 1.8% | 16.3% | ||
| Q1 25 | 10.5% | 41.2% | ||
| Q4 24 | 12.6% | 12.2% | ||
| Q3 24 | 11.8% | 23.7% | ||
| Q2 24 | 3.9% | 12.5% | ||
| Q1 24 | 0.5% | 24.0% |
资本支出强度COORBLX
| Q4 25 | 9.2% | 21.1% | ||
| Q3 25 | 9.1% | 7.5% | ||
| Q2 25 | 7.8% | 2.1% | ||
| Q1 25 | 9.3% | 1.7% | ||
| Q4 24 | 13.7% | 6.5% | ||
| Q3 24 | 8.9% | 3.2% | ||
| Q2 24 | 7.9% | 4.4% | ||
| Q1 24 | 12.7% | 5.8% |
现金转化率COORBLX
| Q4 25 | 2.93× | — | ||
| Q3 25 | 2.66× | — | ||
| Q2 25 | 1.10× | — | ||
| Q1 25 | 1.83× | — | ||
| Q4 24 | 2.28× | — | ||
| Q3 24 | 1.98× | — | ||
| Q2 24 | 1.25× | — | ||
| Q1 24 | 1.51× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
COO
| Sphere Other | $365.0M | 34% |
| Toric And Multifocal | $344.7M | 32% |
| Office And Surgical | $214.5M | 20% |
| Fertility | $140.9M | 13% |
RBLX
暂无分部数据
